| 1 |
Feng Q, Zhang Y, Fang Y, Kong X, He Z, Ji J, Yang X, Zhai G. Research progress of exosomes as drug carriers in cancer and inflammation. J Drug Target 2023;31:335-53. [PMID: 36543743 DOI: 10.1080/1061186X.2022.2162059] [Reference Citation Analysis]
|
| 2 |
Feng J, Wu Y. Endothelial-to-Mesenchymal Transition: Potential Target of Doxorubicin-Induced Cardiotoxicity. Am J Cardiovasc Drugs 2023. [PMID: 36841924 DOI: 10.1007/s40256-023-00573-w] [Reference Citation Analysis]
|
| 3 |
Zhao C, Xing Z, Wei X, Liao G, Yang D, Liu H, Fan Y. Multibiofunctional TFEB-engineered endothelial progenitor cell-derived extracellular vesicles/hydrogel system for rescuing critical limb ischemia. Chemical Engineering Journal 2023. [DOI: 10.1016/j.cej.2023.141730] [Reference Citation Analysis]
|
| 4 |
Shi X, Seidle KA, Simms KJ, Dong F, Chilian WM, Zhang P. Endothelial progenitor cells in the host defense response. Pharmacol Ther 2023;241:108315. [PMID: 36436689 DOI: 10.1016/j.pharmthera.2022.108315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Vinci MC, Carulli E, Rurali E, Rinaldi R, Damiano G, Raucci A, Pompilio G, Genovese S. The Long Telling Story of "Endothelial Progenitor Cells": Where Are We at Now? Cells 2022;12. [PMID: 36611906 DOI: 10.3390/cells12010112] [Reference Citation Analysis]
|
| 6 |
Heinisch PP, Bello C, Emmert MY, Carrel T, Dreßen M, Hörer J, Winkler B, Luedi MM. Endothelial Progenitor Cells as Biomarkers of Cardiovascular Pathologies: A Narrative Review. Cells 2022;11:1678. [DOI: 10.3390/cells11101678] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 7 |
Petroušková P, Hudáková N, Maloveská M, Humeník F, Cizkova D. Non-Exosomal and Exosome-Derived miRNAs as Promising Biomarkers in Canine Mammary Cancer. Life 2022;12:524. [DOI: 10.3390/life12040524] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 8 |
Selvakumar PP, Rafuse MS, Johnson R, Tan W. Applying Principles of Regenerative Medicine to Vascular Stent Development. Front Bioeng Biotechnol 2022;10:826807. [DOI: 10.3389/fbioe.2022.826807] [Reference Citation Analysis]
|
| 9 |
Yang D, Wang M, Hu Z, Ma Y, Shi Y, Cao X, Guo T, Cai H, Cai H. Extracorporeal Cardiac Shock Wave-Induced Exosome Derived From Endothelial Colony-Forming Cells Carrying miR-140-3p Alleviate Cardiomyocyte Hypoxia/Reoxygenation Injury via the PTEN/PI3K/AKT Pathway. Front Cell Dev Biol 2021;9:779936. [PMID: 35083214 DOI: 10.3389/fcell.2021.779936] [Reference Citation Analysis]
|
| 10 |
Mause SF, Ritzel E, Deck A, Vogt F, Liehn EA. Engagement of the CXCL12-CXCR4 Axis in the Interaction of Endothelial Progenitor Cell and Smooth Muscle Cell to Promote Phenotype Control and Guard Vascular Homeostasis. Int J Mol Sci 2022;23:867. [PMID: 35055054 DOI: 10.3390/ijms23020867] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Li J, Zhao Y, Zhu W. Targeting angiogenesis in myocardial infarction: Novel therapeutics (Review). Exp Ther Med 2022;23:64. [PMID: 34934435 DOI: 10.3892/etm.2021.10986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Wei Z, Zhao Y, Hsu P, Guo S, Zhang C, Zhong B. Exosomes for gene therapy effectively inhibit the endothelial-mesenchymal transition in mouse aortic endothelial cells. BMC Musculoskelet Disord 2021;22:1000. [PMID: 34847881 DOI: 10.1186/s12891-021-04896-0] [Reference Citation Analysis]
|
